Utah Medical Products UTMD Weighted-average grant date fair value of stock options (in dollars per share)
Weighted-average grant date fair value of stock options (in dollars per share) at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue.
The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's weighted-average grant date fair value of stock options (in dollars per share).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's weighted-average grant date fair value of stock options (in dollars per share)?
- Utah Medical Products (UTMD) reported weighted-average grant date fair value of stock options (in dollars per share) of $16.74 in Q4 2025.
- What does weighted-average grant date fair value of stock options (in dollars per share) mean?
- The weighted average fair value at the grant date for all stock options granted to employees during the reporting period. This metric represents the estimated cost per option that the company will recognize as compensation expense over the vesting period. It provides transparency into the competitiveness and cost of equity-based incentive programs.